These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12526058)

  • 1. Induction of cellular immunity to varicella-zoster virus glycoproteins tested with pernasal coadministration of Escherichia coli enterotoxin in mice.
    Tsuji T; Shiraki K; Sato H; Sasaki K; Arita M; Kato M; Takahashi T; Ochi S; Ichinose Y; Yokochi T; Asano Y
    J Med Virol; 2003 Mar; 69(3):451-8. PubMed ID: 12526058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant action of Escherichia coli enterotoxin for delayed-type hypersensitivity to Oka vaccine virus on pernasal co-administration in mice.
    Sasaki K; Asano Y; Honma Y; Kamiya N; Handa T; Ichinose Y; Yokochi T; Shiraki K; Tsuji T
    Vaccine; 2000 Nov; 19(7-8):931-6. PubMed ID: 11115718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in mice.
    Kamiya N; Asano Y; Yoshino J; Sasaki K; Honma Y; Kawase H; Yokochi T; Shiraki K; Tsuji T
    Vaccine; 2001 Apr; 19(23-24):3131-6. PubMed ID: 11312008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
    Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
    J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNgamma-stimulated macrophages.
    Shimizu T; Sasaki K; Kato M; Arimitsu H; Ochi S; Yano T; Oguma K; Yokochi T; Tsuji T
    Vaccine; 2006 May; 24(18):3719-26. PubMed ID: 16115702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine.
    Sato H; Kageyama S; Imakita M; Ida M; Yamamura J; Kurokawa M; Shiraki K
    Vaccine; 1998 Aug; 16(13):1263-9. PubMed ID: 9682389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice.
    Tsuji T; Shiraki K; Sato H; Yue-Mea J; Honma Y; Yoshikawa T; Asano Y
    Vaccine; 2000 Apr; 18(19):2049-54. PubMed ID: 10706968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
    Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
    J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
    Erume J; Partidos CD
    Afr Health Sci; 2011 Jun; 11(2):151-7. PubMed ID: 21857843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.
    Richards CM; Aman AT; Hirst TR; Hill TJ; Williams NA
    J Virol; 2001 Feb; 75(4):1664-71. PubMed ID: 11160664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.
    Douce G; Giannelli V; Pizza M; Lewis D; Everest P; Rappuoli R; Dougan G
    Infect Immun; 1999 Sep; 67(9):4400-6. PubMed ID: 10456880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
    Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
    J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.
    Alkadah A; Thiam F; Mounier M; Charpilienne A; Poncet D; Kohli E; Basset C
    Vaccine; 2013 Apr; 31(15):1924-30. PubMed ID: 23453731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
    Nawar HF; Arce S; Russell MW; Connell TD
    Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.